UK Markets open in 3 hrs 4 mins

Bayer shares up after first trial win over Roundup

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

BERLIN (Reuters) - Shares in Bayer AG rose 2.5% in pre-market trade on Wednesday after the German agricultural and pharmaceuticals firm won its first trial over claims its Roundup weedkiller causes cancer.

A California jury found that the herbicide was not a substantial cause of a child's rare form of non-Hodgkin's lymphoma, the company said on Tuesday. The verdict is the fourth involving Roundup and the first in the company's favor.

Roundup-related lawsuits have dogged Bayer since it acquired the brand as part of its $63 billion purchase of agricultural seeds and pesticides maker Monsanto in 2018.

(Reporting by Emma Thomasson; Editing by Muralikumar Anantharaman)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting